GB861779A - Piperazino derivatives and methods for their manufacture - Google Patents
Piperazino derivatives and methods for their manufactureInfo
- Publication number
- GB861779A GB861779A GB29074/57A GB2907457A GB861779A GB 861779 A GB861779 A GB 861779A GB 29074/57 A GB29074/57 A GB 29074/57A GB 2907457 A GB2907457 A GB 2907457A GB 861779 A GB861779 A GB 861779A
- Authority
- GB
- United Kingdom
- Prior art keywords
- acetyl
- group
- lower alkyl
- alkyl group
- phenthiazine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- -1 Piperazino Chemical class 0.000 title abstract 10
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 8
- 150000001875 compounds Chemical class 0.000 abstract 7
- MOMFXATYAINJML-UHFFFAOYSA-N 2-Acetylthiazole Chemical group CC(=O)C1=NC=CS1 MOMFXATYAINJML-UHFFFAOYSA-N 0.000 abstract 4
- 239000002253 acid Substances 0.000 abstract 3
- 125000004432 carbon atom Chemical group C* 0.000 abstract 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 3
- MFESCIUQSIBMSM-UHFFFAOYSA-N I-BCP Chemical compound ClCCCBr MFESCIUQSIBMSM-UHFFFAOYSA-N 0.000 abstract 2
- 125000002947 alkylene group Chemical group 0.000 abstract 2
- 238000006243 chemical reaction Methods 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 abstract 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 abstract 2
- NSMWYRLQHIXVAP-UHFFFAOYSA-N 2,5-dimethylpiperazine Chemical compound CC1CNC(C)CN1 NSMWYRLQHIXVAP-UHFFFAOYSA-N 0.000 abstract 1
- DEMJSCKEDLLJBK-UHFFFAOYSA-N 2-(2,5-dimethylpiperazin-1-yl)ethanol Chemical compound CC1CN(CCO)C(C)CN1 DEMJSCKEDLLJBK-UHFFFAOYSA-N 0.000 abstract 1
- PPXLQETZAQHSSL-UHFFFAOYSA-N 2-[4-(3-chloropropyl)piperazin-1-yl]ethanol Chemical compound OCCN1CCN(CCCCl)CC1 PPXLQETZAQHSSL-UHFFFAOYSA-N 0.000 abstract 1
- ZXNMIUJDTOMBPV-UHFFFAOYSA-N 2-chloroethyl 4-methylbenzenesulfonate Chemical compound CC1=CC=C(S(=O)(=O)OCCCl)C=C1 ZXNMIUJDTOMBPV-UHFFFAOYSA-N 0.000 abstract 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 abstract 1
- WFCSWCVEJLETKA-UHFFFAOYSA-N 2-piperazin-1-ylethanol Chemical compound OCCN1CCNCC1 WFCSWCVEJLETKA-UHFFFAOYSA-N 0.000 abstract 1
- RQFUZUMFPRMVDX-UHFFFAOYSA-N 3-Bromo-1-propanol Chemical compound OCCCBr RQFUZUMFPRMVDX-UHFFFAOYSA-N 0.000 abstract 1
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 abstract 1
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 abstract 1
- PHSPJQZRQAJPPF-UHFFFAOYSA-N N-alpha-Methylhistamine Chemical compound CNCCC1=CN=CN1 PHSPJQZRQAJPPF-UHFFFAOYSA-N 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 229940125717 barbiturate Drugs 0.000 abstract 1
- YHASWHZGWUONAO-UHFFFAOYSA-N butanoyl butanoate Chemical compound CCCC(=O)OC(=O)CCC YHASWHZGWUONAO-UHFFFAOYSA-N 0.000 abstract 1
- 239000000969 carrier Substances 0.000 abstract 1
- 229920005556 chlorobutyl Polymers 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 229960003750 ethyl chloride Drugs 0.000 abstract 1
- 230000007062 hydrolysis Effects 0.000 abstract 1
- 238000006460 hydrolysis reaction Methods 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 238000007911 parenteral administration Methods 0.000 abstract 1
- AHWALFGBDFAJAI-UHFFFAOYSA-N phenyl carbonochloridate Chemical compound ClC(=O)OC1=CC=CC=C1 AHWALFGBDFAJAI-UHFFFAOYSA-N 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 229910052698 phosphorus Inorganic materials 0.000 abstract 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 1
- 239000008174 sterile solution Substances 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D281/02—Seven-membered rings
- C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D281/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
- C07D281/16—[b, f]-condensed
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention comprises compounds of the general formula <FORM:0861779/IV (b)/1> and their pharmaceutically acceptable acid addition salts (wherein R is a lower alkyl group, R1 is a hydrogen atom or a lower alkyl group, Y is an alkylene group with 2 to 5 carbon atoms, and A is a free, etherified or esterified hydroxy lower alkyl group), and the preparation thereof by reacting a compound of the general formula <FORM:0861779/IV (b)/2> with a compound of the general formula <FORM:0861779/IV (b)/3> preferably in the presence of an acceptor for PQ, and followed, if necessary, by the conversion of A1 into A and Y1 into Y (wherein of P and Q, one is attached directly to the relevant nitrogen atom and the other is connected to the relevant nitrogen atom through a divalent group Y1, A1 being A or a group convertible into A, and Y1 being Y or a group convertible into Y, P and Q being groups of opposite polarity capable of being eliminated as the compound PQ during the course of the reaction). In the examples, A, when representing an etherified or esterified hydroxy lower alkyl group, may be a hydroxyethoxyethyl group, an acetoxyethyl group, an ethoxycarboxyethyl group, a carbamoylethyl or dimethylcarbamoylethyl group. A lower alkyl group contains less than 6 carbon atoms. 10 - (3 - Chloropropyl) - 2 - acetylphenthiazine is made from 2-acetyl-phenthiazine and 1-bromo-3-chloropropane. Similarly made are 10-(4) - chlorobutyl) - 2 - acetyl - phenthiazine and 10-(3-chloropropyl)-2-propionylphenthiazine. 2 - (2 - Acetyl - 10 - phenthiazinyl) - ethyl chloride is made from 2-acetyl-phenthiazine and 2-chloro-ethyl-p-toluenesulphonate. 2 - Acetyl - phenthiazine is reacted with 1, 2 oxidopropane to give 3 - (2 - acetyl - 10 - phenthiazinyl) - propan - 2 - ol, treatment of which with phosphorus tribromide yields the corresponding bromo compound. 2 - Propionyl - phenthiazine is reacted with 3 - bromo - propan - 1 - ol to give 3 - (2 - propionyl - 10 - phenthiazioyl) - propan - 1 - ol, treatment of which with p-toluenesulphonyl chloride yields the corresponding p-toluene-sulphonic acid ester. 10 - Acetyl - phenthiazine is reacted with butyric anhydride to give 2-butyryl-10-acetyl-phenthiazine, hydrolysis of which yields 2-butyrylphenthiazine. 1 - (2 - Hydroxyethyl) - 4 - [3 - (2 - acetyl - 10-phenthiazinyl)propyl]-piperazine is reacted with thionyl chloride to give the corresponding chloro compound or reacted phenyl chlorocarbonate to yield the corresponding phenyl carbonic ester. 1 - (2 - Hydroxyethyl) - 2,5 - dimethylpiperazine is made from 2,5-dimethyl piperazine and ethylene oxide; and 1 - (2 - hydroxyethyl) - 4 - (3-chloropropyl)-piperazine is made from 1-(2-hydroxyethyl)-piperazine and 1-bromo-3-chloropropane.ALSO:Compounds of the general formula <FORM:0861779/VI/1> (wherein R is a lower alkyl group, R1 is a hydrogen atom or a lower alkyl group, Y is an alkylene group with 2 to 5 carbon atoms, and A is a free, etherified or esterified hydroxy lower alkyl group) are preferably compounded in the form of soluble, pharmaceutically acceptable, acid addition salts, e.g. the dihydrochloride, dicitrate, dimaleate or ditartrate. They are preferably administered orally in tablets or elixirs in conjunction with suitable carriers and other types of oral, pharmaceutical dosage units. For parenteral administration, the compounds in the form of non-toxic, acid addition salts are prepared in sterile solutions or suspensions. The compounds may be used, advantageously in conjunction with barbiturates, to reduce anxiety.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CS356132X | 1956-08-09 | ||
US861779XA | 1956-09-21 | 1956-09-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB861779A true GB861779A (en) | 1961-02-22 |
Family
ID=25746761
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB25135/57A Expired GB866791A (en) | 1956-08-09 | 1957-08-09 | A process for preparing new physiologically effective salts of the aminoalkyl derivatives of homophenothiazine |
GB29074/57A Expired GB861779A (en) | 1956-08-09 | 1957-09-16 | Piperazino derivatives and methods for their manufacture |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB25135/57A Expired GB866791A (en) | 1956-08-09 | 1957-08-09 | A process for preparing new physiologically effective salts of the aminoalkyl derivatives of homophenothiazine |
Country Status (4)
Country | Link |
---|---|
CH (2) | CH356132A (en) |
DE (1) | DE1141286B (en) |
FR (1) | FR1187023A (en) |
GB (2) | GB866791A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3188320A (en) * | 1965-06-08 | Peepaeation of io-[j-(n-methylformamido) peopylj-lo.ll-dihydeo |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2694705A (en) * | 1954-11-16 | Nx c c ox a a | ||
GB666457A (en) * | 1948-10-30 | 1952-02-13 | Henri Morren | Carbonyl chlorides and monocarboxyamides of piperazine and process for the preparation thereof |
DE910301C (en) * | 1950-12-21 | 1954-04-29 | Rhone Poulenc Sa | Process for the production of new phenthiazine derivatives |
CH298685A (en) * | 1951-06-28 | 1954-05-15 | Rhone Poulenc Chemicals | Process for the preparation of a novel derivative of phenothiazine. |
DE922467C (en) * | 1951-11-25 | 1955-01-17 | Cassella Farbwerke Mainkur Ag | Process for the preparation of N-derivatives of phenothiazine |
-
1957
- 1957-07-24 CH CH356132D patent/CH356132A/en unknown
- 1957-07-24 CH CH356133D patent/CH356133A/en unknown
- 1957-08-09 GB GB25135/57A patent/GB866791A/en not_active Expired
- 1957-08-09 FR FR1187023D patent/FR1187023A/en not_active Expired
- 1957-09-16 GB GB29074/57A patent/GB861779A/en not_active Expired
- 1957-09-20 DE DESCH22823A patent/DE1141286B/en active Pending
Also Published As
Publication number | Publication date |
---|---|
GB866791A (en) | 1961-05-03 |
CH356133A (en) | 1961-08-15 |
CH356132A (en) | 1961-08-15 |
DE1141286B (en) | 1962-12-20 |
FR1187023A (en) | 1959-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3919290A (en) | Substituted 14-desoxy-mutilins | |
EP0720605A1 (en) | Aminocyclohexylesters and uses thereof | |
US2870145A (en) | Therapeutic agents | |
EP0541617B1 (en) | 1,4-disubstituted piperazines | |
US2899436A (en) | chjch | |
GB1567958A (en) | Piperazine and piperazine homologue derivatives and preparation and use thereof | |
GB850662A (en) | Substituted piperazines and processes for their production | |
US4390537A (en) | 1-(Substituted-aminoalkoxyphenyl)-2-methylene-1-alkanones, compositions and use | |
US4342782A (en) | 1-(Substituted-aminoalkoxyphenyl)-2-methylene-1-alkanones, compositions and use thereof | |
GB861779A (en) | Piperazino derivatives and methods for their manufacture | |
US3884922A (en) | 11-(4-Pyridylalkyl-piperazino)-dibenzothiazepines | |
US4259334A (en) | Piperazines and therapeutic utility | |
GB822777A (en) | Improvements in or relating to halophenothiazine derivatives | |
US2802003A (en) | Derivatives of 3-azabicycloheptane | |
US2551316A (en) | 9-aminoalkyl 9-alkanoyl 9, 10 dihydroanthracenes | |
US3531523A (en) | N-(phenoxyphenyl)sulfamides | |
US3624086A (en) | Adamantanecarboxamidoalkanoic acid amides | |
US4101671A (en) | Aminobenzyl-amines and salts thereof | |
US5276035A (en) | 1,4-disubstituted piperazines | |
US3826833A (en) | Cns-depressant compositions and method with(4-(10,11-dihydrodibenz(b,f)oxepin-10-yl)-1-piperazinyl)-alkyl-3-alkyl-2-imidazolidinones | |
GB833473A (en) | ||
US3625969A (en) | 6-sulfamyl-4-hydroxy-3-carboxy-quinolines | |
GB875348A (en) | Improvements in or relating to trifluormethyl substituted phenoxazines | |
US4091114A (en) | Pharmaceutically active 2-omega-aminoalkoxydiphenylmethanes | |
GB1135907A (en) | Process for the production of coumarin derivatives |